N-(3-pyridinylmethyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrobromide, 95.0%, 1g

2-(2-Chlorophenoxy)propanohydrazide, 95.0%, 1g

2,5-Dichloropyrimidine, 97.0%, 50g

(R)-tert-Butyl (1-(methoxy(methyl)amino)-1-oxopropan-2-yl)(methyl)carbamate, 97%, 1g

Fmoc-Asp(OMe)-OH, 95%, 10g

1-(3,5-Bis(trifluoromethyl)phenyl)-3-((S)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)thiourea, 98%, 250mg

2,7-Diamino-9,9-di-n-octylfluorene>98.0%(HPLC)(T)200mg

(R)-4-Benzyl-2-(5-fluoropyridin-2-yl)-4,5-dihydrooxazole, 97%, 100mg

Graphite, natural, amorphous, 500 g, plastic packaging.

5-Bromo-3-nitropyridine-2-carboxylic acid, 95.0%, 250mg

(2R,4R)-1-BOC-2-METHYL-4-HYDROXYPIPERIDINE, 95.0%, 5g

2-Chloro-1-{4-[(2-methylphenyl)methyl]piperazin-1-yl}ethan-1-one hydrochloride, 98%, 250mg

3-Methyl-4-nitroisoxazol-5-amine, 97%, 1g